The effect of lutein and Zeaxanthine on dyslipidemia: A meta-analysis study

Abstract

AIMS: The relationship between circulating Lutein and zeaxanthin (L/Z) concentrations, and plasma lipoproteins has been indicated by observational studies. However, the beneficial impact of L/Z administration on dyslipidemia are unclear. This meta-analysis aimed to investigate the effect of oral intake of L/Z on circulating total cholesterol (TC), low-density lipoprotein-cholesterol (LDL-C), as well as high-density lipoprotein-cholesterol (HDL-C) levels. METHODS: We electronically assessed all eligible interventional studies through different electronic databases, including PubMed, Scopus, ISI -Web of Science, and Cochrane library until Jun 2021. After identifying the quality of each included randomized controlled trials, they were evaluated by assessing the risk-difference between treatment and control groups by pooling available data on net change of serum LDL-C, HDL-C, and Cholesterol. RESULTS: L/Z supplementation has null effect on circulating levels of TC (WMD: -3.82 95 CI: -13.83, 6.18; I-square: 85.2), and LDL-C (WMD: -4.54; 95 CI: -11.5, 2.48; I-square: 83.9). In contrast, L/Z treatment could significantly increase HDL-C levels in older adults (WMD: 4.06; 95 CI: 0.64, 7.48; I-square: 50.7). CONCLUSION: L/Z administration could be an effective treatment for improving circulating HDL-C concentration in elderly adults.